Gemcitabine
DrugBank ID: DB00441
Summary
| Metric | Value |
|---|---|
| Total Predictions | 59 |
| KG+DL (Dual Validated) | 10 |
| DL Only | 40 |
| KG Only | 9 |
Predictions
| Indication | Score | Source |
|---|---|---|
| female breast carcinoma | 0.9998 | DL |
| hereditary breast ovarian cancer syndrome | 0.9996 | DL |
| ovarian clear cell adenocarcinoma | 0.9994 | KG+DL |
| primary non-gestational choriocarcinoma of ovary | 0.9990 | KG+DL |
| maligant granulosa cell tumor of ovary | 0.9985 | KG+DL |
| ovarian mucinous adenocarcinoma | 0.9985 | KG+DL |
| ovarian endometrioid adenocarcinoma | 0.9982 | KG+DL |
| yolk sac tumor | 0.9982 | KG+DL |
| ovarian small cell carcinoma | 0.9977 | KG+DL |
| rectum mucinous adenocarcinoma | 0.9977 | DL |
| colon mucinous adenocarcinoma | 0.9976 | DL |
| endometrial mixed adenocarcinoma | 0.9976 | DL |
| villoglandular endometrial endometrioid adenocarcinoma | 0.9976 | DL |
| malignant non-dysgerminomatous germ cell tumor of ovary | 0.9976 | KG+DL |
| endometrial mucinous adenocarcinoma | 0.9975 | DL |
| cervical mucinous adenocarcinoma | 0.9975 | DL |
| gallbladder mucinous adenocarcinoma | 0.9975 | DL |
| malignant germ cell tumor of ovary | 0.9974 | KG+DL |
| rete ovarii adenocarcinoma | 0.9973 | DL |
| mucin-rich endometrial endometrioid adenocarcinoma | 0.9973 | DL |
| secretory uterine corpus endometrioid adenocarcinoma | 0.9973 | DL |
| Krukenberg carcinoma | 0.9973 | DL |
| extrahepatic bile duct mucinous adenocarcinoma | 0.9973 | DL |
| adult germ cell tumor | 0.9973 | DL |
| lung colloid adenocarcinoma | 0.9972 | DL |
| ovarian cystadenocarcinoma | 0.9972 | DL |
| stage I endometrioid carcinoma | 0.9970 | DL |
| stage II endometrioid carcinoma | 0.9970 | DL |
| cervical endometrioid adenocarcinoma | 0.9967 | DL |
| mediastinal malignant germ cell tumor | 0.9967 | DL |
| enteric pattern testicular yolk sac tumor | 0.9967 | DL |
| polyvesicular vitelline pattern testicular yolk sac tumor | 0.9967 | DL |
| reticular pattern testicular yolk sac tumor | 0.9967 | DL |
| testicular yolk sac tumor, endodermal sinus pattern | 0.9967 | DL |
| testicular yolk sac tumor, hepatoid pattern | 0.9967 | DL |
| testicular yolk sac tumor, macrocystic pattern | 0.9967 | DL |
| testicular yolk sac tumor, papillary pattern | 0.9967 | DL |
| testicular yolk sac tumor, solid pattern | 0.9967 | DL |
| malignant dysgerminomatous germ cell tumor of ovary | 0.9966 | KG+DL |
| childhood ovarian yolk sac tumor | 0.9966 | DL |
| ovarian yolk sac tumor, glandular pattern | 0.9965 | DL |
| ovarian yolk sac tumor, hepatoid pattern | 0.9965 | DL |
| ovarian yolk sac tumor, polyvesicular vitelline pattern | 0.9965 | DL |
| ovarian cystic teratoma | 0.9964 | DL |
| familial ovarian cancer | 0.9962 | DL |
| malignant struma ovarii | 0.9958 | DL |
| breast-ovarian cancer, familial, susceptibility to | 0.9958 | DL |
| malignant germ cell tumor of cervix uteri | 0.9956 | DL |
| ovarian biphasic or triphasic teratoma | 0.9955 | DL |
| ovarian mixed germ cell neoplasm | 0.9955 | DL |
Showing top 50 of 59 predictions.
External Links
Disclaimer
Predictions are for research purposes only and do not constitute medical advice.
Predictions are for research purposes only and do not constitute medical advice.